244 related articles for article (PubMed ID: 31472915)
1. Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma.
Mondaca S; Yarmohammadi H; Kemeny NE
Surg Oncol Clin N Am; 2019 Oct; 28(4):717-729. PubMed ID: 31472915
[TBL] [Abstract][Full Text] [Related]
2. Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
Monier A; Guiu B; Duran R; Aho S; Bize P; Deltenre P; Dunet V; Denys A
Eur Radiol; 2017 Apr; 27(4):1431-1439. PubMed ID: 27436016
[TBL] [Abstract][Full Text] [Related]
3. Role of Radioembolization for Biliary Tract and Primary Liver Cancer.
Taylor AC; Maddirela D; White SB
Surg Oncol Clin N Am; 2019 Oct; 28(4):731-743. PubMed ID: 31472916
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
[TBL] [Abstract][Full Text] [Related]
5. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
Harris WP; Wong KM; Saha S; Dika IE; Abou-Alfa GK
Semin Oncol; 2018 Jun; 45(3):116-123. PubMed ID: 30348531
[TBL] [Abstract][Full Text] [Related]
6. Advances in regional chemotherapy of the liver.
Dudeck O; Ricke J
Expert Opin Drug Deliv; 2011 Aug; 8(8):1057-69. PubMed ID: 21506902
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
11. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
12. Molecular Characteristics of Biliary Tract and Primary Liver Tumors.
Tsai S; Gamblin TC
Surg Oncol Clin N Am; 2019 Oct; 28(4):685-693. PubMed ID: 31472913
[TBL] [Abstract][Full Text] [Related]
13. Diffuse biliary peritonitis secondary to rupture of metastatic liver adenocarcinomas after drug-eluting bead transcatheter arterial chemoembolization: a case report.
Zhu LB; Li TF; Li JQ; Li PF; Zhang PB; Wu HB; Xv R
J Int Med Res; 2019 Jun; 47(6):2679-2686. PubMed ID: 30971156
[TBL] [Abstract][Full Text] [Related]
14. Intraarterial Therapies for the Management of Hepatocellular Carcinoma.
Garg T; Shrigiriwar A; Habibollahi P; Cristescu M; Liddell RP; Chapiro J; Inglis P; Camacho JC; Nezami N
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884412
[TBL] [Abstract][Full Text] [Related]
15. Inoperable Biliary Tract and Primary Liver Tumors: Palliative Treatment Options.
McKinley SK; Chawla A; Ferrone CR
Surg Oncol Clin N Am; 2019 Oct; 28(4):745-762. PubMed ID: 31472917
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
17. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
DeLeon TT; Ahn DH; Bogenberger JM; Anastasiadis PZ; Arora M; Ramanathan RK; Aqel BA; Vasmatzis G; Truty MJ; Oklu R; Bekaii-Saab TS; Borad MJ
Future Oncol; 2018 Mar; 14(6):553-566. PubMed ID: 29460642
[TBL] [Abstract][Full Text] [Related]
18. Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization.
Fujita M; Okai K; Hayashi M; Abe K; Takahashi A; Kimura T; Kenjo A; Marubashi S; Hashimoto Y; Ohira H
Intern Med; 2019 Apr; 58(8):1103-1110. PubMed ID: 30626806
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
20. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
